Skip to content

STRATOFUSE Strip BA42-501005

by Berkeley Advanced Biomaterials

STRATOFUSE Strip BA42-501005 is an orthopaedic bone void filling material (FDA Class II; FDA product code MQV, Filler, Bone Void, Calcium Compound) made by Berkeley Advanced Biomaterials, cleared under FDA 510(k) K092046 on 24 Mar 2010 and listed in FDA GUDID since 12 May 2017 (UDI-DI 00858418003997), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K092046

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00858418003997 UDI-DI Date12 May 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Special NumberK092046 Date24 Mar 2010DecidedStatusActive

Official records

From the FDA record

Device description
STRATOFUSE is a sterile bone graft composed of purified fibrillar type I collagen and 60% hydroxyapatite - 40% tricalcium phosphate resorbable granules. This device, formulated as a block (strip), is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone. STRATOFUSE is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30ml.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K092046 decided 24 Mar 2010 Active
  • FDA GUDID UDI-DI 00858418003997 listed 12 May 2017 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K092046
  2. Listed FDA GUDID 00858418003997

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
STRATOFUSE Strip
Generic name
Orthopaedic bone void filling material, synthetic/animal-derived
Model / Ref / Catalog
BA42-501005
Primary DI / UDI-DI
00858418003997
510(k) Number
FDA product code
MQV
GMDN term
Orthopaedic bone void filling material, synthetic/animal-derived
Device class
Class II
Regulation number
888.3045
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code MQV (Filler, Bone Void, Calcium Compound).

Other devices from Berkeley Advanced Biomaterials

See all devices from Berkeley Advanced Biomaterials →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Serial number
  • Expiration date
Other properties (8, all answered No)